Gastroenterology 136(7):21592168
The terminology is contested, but the underlying observation is not: the metabolic deterioration of neurons, their diminishing capacity to produce and manage energy, appears to be an early and potentially modifiable feature of the disease process, not merely a downstream consequence of it
What dosing information exists for MT-1
When starting a GLP-1 medication, understanding how your body may respond to different foodsespecially high-fat or high-sugar options like chocolatehelps set realistic expectations and supports sustainable dietary patterns
In April 2023, KFF fielded a survey to a nationally representative sample of 1,479 adults in the United States from the SSRS Opinion Panel to obtain population estimates of GLP-1 agonist knowledge, attitudes, and use (Montero et al., 2024)
F., Zdravkovic, M